Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.54 |
| ▸ | MAOB | P27338 | 10/20 | 0.53 |
| ▸ | MAOA | P21397 | 9/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.48 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.45 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7371944 | 0.84 | NPC1 (0.52) | SPHK1MAOBMAOANPC1RAB9A | |
| SCHEMBL7365784 | 0.78 | ADAM17 (0.52) | SPHK1MAOBMAOANPC1RAB9A | |
| SCHEMBL7371153 | 0.77 | SPHK1 (0.57) | SPHK1MAOBMAOANPC1RAB9A | |
| SCHEMBL7341840 | 0.76 | SPHK1 (0.54) | SPHK1MAOBMAOANPC1RAB9A | |
| SCHEMBL7365257 | 0.76 | SPHK1 (0.50) | SPHK1MAOBMAOANPC1RAB9A | |
| SCHEMBL7371918 | 0.74 | ADAM17 (0.49) | SPHK1MAOBMAOANPC1RAB9A | |
| SCHEMBL7366397 | 0.74 | SPHK1 (0.58) | SPHK1MAOBMAOANPC1RAB9A | |
| SCHEMBL7366749 | 0.74 | LTA4H (0.52) | NPC1RAB9A | |
| SCHEMBL7370196 | 0.74 | NPC1 (0.55) | SPHK1MAOBNPC1RAB9A | |
| SCHEMBL7405693 | 0.73 | MAOB (0.54) | SPHK1MAOBMAOANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6117841-A | USED TO TREAT STROKE, CEREBRAL ISCHEMIA, PAIN, HEAD TRAUMA OR EPILEPSY | WARNER-LAMBERT COMPANY (US) | 2000-09-12 | — | — | US | claimed |
| WO-1998054123-A1 | SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS | WARNER-LAMBERT COMPANY (US) | 1998-12-03 | — | — | WO | claimed |
| US-6117841-A | USED TO TREAT STROKE, CEREBRAL ISCHEMIA, PAIN, HEAD TRAUMA OR EPILEPSY | WARNER-LAMBERT COMPANY (US) | 2000-09-12 | — | — | US | disclosed |
| WO-1998054123-A1 | SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS | WARNER-LAMBERT COMPANY (US) | 1998-12-03 | — | — | WO | disclosed |